FindTrial
Sign In

Mouthwash and its role in reducing gingival inflammation

comparative evaluation of boric acid with chlorhexidine mouthwash in plaque induced gingivitis treatment- a double blind randomised controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039685
Enrollment
80
Registered
2022-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: boric acid and chlorhexidine mouth as an adjunct to treatment of plaque induced gingivitis: The study groups will comprise of Group A-35 subjects received scaling and root planing (SRP)

Sponsors

Swet Nisha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects aged >18 years with Plaque-induced gingivitis a minimum of 20 teeth

Exclusion criteria

Exclusion criteria: Subjects with any systemic disease smokers mucosal lesions anti-inflammatory/antimicrobial drugs in past 6 months pregnant lactating mother patient on supportive periodontal therapy, use of mouthwash vitamin supplements in last 6 months, patients diagnosed with periodontitis underwent periodontal therapy in past 12 months.

Design outcomes

Primary

MeasureTime frame
plaque index,gingival index,bleeding on probingTimepoint: baseline,14th day and 21st day—

Secondary

MeasureTime frame
bleeding on probingTimepoint: baseline,14th day and 21st day—

Countries

India

Contacts

Public ContactSwet Nisha

Haldia Institute Of Dental Sciences and Research

swetnisha1@gmail.com9883916227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026